Rylaze 10 MG/0.5 ML vial 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FL5G5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $60,027
Award facts
- Contract value 100% obligated
- $60,027.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $60,027.03 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of RYLAZE 10 mg/0.5 ml vials. The contract employs firm fixed-price pricing with a completion deadline of December 1, 2025. This non-competitive set-aside award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills delivery orders through its DLA prime contract vehicle to supply specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The company's federal contracting demonstrates extensive capability in supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and competitively awarded contract mechanisms. This RYLAZE delivery order represents one of numerous pharmaceutical supply transactions the vendor executes to meet military medical requirements.
Quick answers
Who was awarded contract SPE2DB26FL5G5?
SPE2DB26FL5G5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FL5G5 worth?
The government has obligated $60,027 on SPE2DB26FL5G5.
Is contract SPE2DB26FL5G5 an order under another contract?
Yes. SPE2DB26FL5G5 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB26FL5G5 competed?
The extent of competition for SPE2DB26FL5G5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award